Skip to main content
CiMUS Seminar

Emerging pathways: Body weight biology and weight loss pharmacotherapy

Christoffer Clemmensen

Novo Nordisk Foundation Center for Basic Metabolic Research (CBMR), Faculty of Health and Medical Sciences, University of Copenhagen, Denmark

27 September 2024 13:00–14:00

Theatre room, CiMUS

This presentation explores recent advances in targeting novel neurobiological pathways, specifically glutamatergic neuroplasticity, for weight loss. Additionally, it will present data from translational overfeeding studies that utilize controlled overfeeding to examine the homeostatic defence mechanisms against positive energy balance.

CV highlights and research lines:
Christoffer Clemmensen is an Associate Professor at the Novo Nordisk Foundation Center for Basic Metabolic Research (CBMR) at the University of Copenhagen, Denmark. Since 2024, he has also led CBMR's Innovation Team. Research in the Clemmensen Group focuses on body weight homeostasis, neuroplasticity in appetite control, and weight loss pharmacology. Christoffer is the Chief Scientific Officer and co-founder of Ousia Pharma, specializing in peptide-drug conjugates for metabolic and brain diseases. He has authored over 90 scientific papers cited more than 7900 times.

Host PI: Rubén Nogueiras. Molecular Metabolism Group, CiMUS

Certificates of attendance will be provided upon request to cimus.xestion [at] (cimus[dot]xestion[at]usc[dot]es). Please do not forget to enter your name and surname on the printout. If you fail to do so, we will not be responsible for changing anyone's record.